Search Results
21 items found for "Chris De Graaf"
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Dimerization: Unveiling Its Role in Receptor Function and Signaling Sonja Peter , Brian Bender , Chris De Graaf for their excellent work on Comparative Study of Allosteric GPCR Binding Sites and Their
- Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for ...
April 2022 Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal (Strasbourg, France; CEO: Pascal Neuville ; “Domain”) and Université de Montréal (Québec, Canada; “UdM
- Unlocking the Future of Medicine: Advancements in GPCR Research
This week's highlight includes congrats to Omolade Otun , Chris de Graaf , Cherine Bechara , et al.
- Dr. Tim De Groof - Dr. GPCR Podcast
Tim De Groof! It’s not often when you get the best of both worlds - nano-bodies and #GPCRs.
- Michel Bouvier appointed Knight of the Ordre national du Québec
the Department of Biochemistry and Molecular Medicine of the Faculty of Medicine of the Université de
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
Chris Cargill appointed as President and Chief Executive Officer • Dr.
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
De novo drug design: AI algorithms can generate new molecules with desired properties, such as binding chemical space, limiting their ability to identify truly novel chemotypes”(Thomas, Smith, O’Boyle, de Graaf & Bender, 2021) and 4) limit of input data can lead to a phenomenon called “the burden of sequence
- 📰 GPCR Weekly News, October 9 to 15, 2023
success Sosei and PharmEnable extend neurological disease drugs hunt Sosei Heptares’ President & CEO Chris
- 📰 GPCR Weekly News
INV-202, an Oral, Peripherally-acting CB1 Inverse Agonist, in Patients with Diabetic Kidney Disease Chris
- Adhesion GPCR Consortium Newsletter - May 2024
Member Profile Antony Boucard Professor Centro de Investigación y de Estudios Avanzados del IPN (Cinvestav AB: Favorite Taco: Taco de suadero (pronounced swa-day-ro), fatty, with meat caramelized in its own fat
- 📰 GPCR Weekly News, October 16 to 22, 2023
Topline Safety and Tolerability Data from Proof-of-Concept Studies Sosei Heptares’ President & CEO Chris
- 📰 GPCR Weekly News, February 13 to 19, 2023
From the scientist’s view: a conversation with … Chris Tate AI is dreaming up drugs that no one has ever
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
Graaf, C., et al., Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March
- 📰 GPCR Weekly News, March 6 to 12, 2023
Domain Therapeutics was nominated for the Trophée de l'Innovation Technologique (Technological Innovation
- Therapeutic validation of an orphan G protein‐coupled receptor
Therefore, matching a ligand to an orphan GPCRs, the process of de-orphanizing, is of great importance
- 📰 GPCR Weekly News, April 10 to 16, 2023
Michel Bouvier received the title of Doctor Honoris Causa from the Université de Montpellier Domain Therapeutics
- 📰 GPCR Weekly News, April 8 to 14, 2024
This week's highlight includes congrats to: Tessa de Vries, Graham Ladds, Antoinette MaassenVanDenBrink
- 📰 GPCR Weekly News, March 27 to April 4, 2023
ended 31 December 2022 Addex Raises $5.0 Million in Equity Financing Testing the limits of SMILES-based de
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
., Rodríguez De Fonseca, F., Puente, N., Marsicano, G., & Grandes, P. (2016).
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
Cary, B.P., et al., New Insights into the Structure and Function of Class B1 GPCRs.
- Nanobodies: New Dimensions in GPCR Signaling Research
., Choi, H. J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., Devree, B. T., Rosenbaum, D.